tiprankstipranks
pc:popla

Poplar Therapeutics

Therapeutics
A clinical-stage immunology company developing a new class of anti-IgE therapy to treat food allergy and other atopic conditions. Its lead program, PHB-050, is a next-generation anti-IgE antibody with a triple-action mechanism designed to block IgE binding, rapidly reduce circulating IgE, and inhibit its production to address multiple atopic diseases.

Leadership & Board

Currently, no data available

Latest Estimated Valuation

Estimated Valuation―
Estimated Valuation―
Total Amount Raised$50M
Total Amount Raised$50M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$50M
Latest Funding Amount$50M
Latest Funding RoundSeries A
Latest Funding RoundSeries A
Post-Money Valuation―
Post-Money Valuation―

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Jan 07, 2026
Series A
$50.00M
―

Investors

Investor Name
Funding Round
SR One
Series A
Platanus
Series A
Vida Ventures
Series A

Related News and Analysis

Deel Launches Global Startup Pitch Program With Multi-Stage Investment Pool

Deel Launches Global Startup Pitch Program With Multi-Stage Investment Pool

According to a recent LinkedIn post from Deel, the company is organizing “The Pitch by Deel,” a startup...
16h ago
DEELX
Deel Highlights Rapid Global Growth in Cross-Border AI Trainer Hiring

Deel Highlights Rapid Global Growth in Cross-Border AI Trainer Hiring

According to a recent LinkedIn post from Deel, the company highlights rapid global growth in demand for AI...
16h ago
DEELX
Talkdesk Targets Healthcare Growth Through Presence at Becker’s Annual Meeting

Talkdesk Targets Healthcare Growth Through Presence at Becker’s Annual Meeting

According to a recent LinkedIn post from Talkdesk, the company is sending a team to the Becker’s Healthcare...
16h ago
TLKDS
Talkdesk Deployment at Johns Hopkins Medicine Signals Healthcare Traction

Talkdesk Deployment at Johns Hopkins Medicine Signals Healthcare Traction

According to a recent LinkedIn post from Talkdesk, Johns Hopkins Medicine is now live on the company’s customer...
16h ago
TLKDS
Databricks Highlights Serverless, Developer-Centric App Building in New Webinar

Databricks Highlights Serverless, Developer-Centric App Building in New Webinar

According to a recent LinkedIn post from Databricks, the company is promoting a webinar focused on building and...
16h ago
DTBRK
Databricks Highlights Iceberg v3 Public Preview and Ongoing Open Data Architecture Efforts

Databricks Highlights Iceberg v3 Public Preview and Ongoing Open Data Architecture Efforts

According to a recent LinkedIn post from Databricks, the company is highlighting the public preview of Iceberg v3...
16h ago
DTBRK
Insurtech Focuses on Document Data Quality to Improve Auto Insurance Profitability

Insurtech Focuses on Document Data Quality to Improve Auto Insurance Profitability

According to a recent LinkedIn post from Upstage, the company is emphasizing that auto insurance profitability depends heavily...
16h ago
UPSTA
KROMATID Highlights Visibility Challenges in In Vivo Gene Therapy

KROMATID Highlights Visibility Challenges in In Vivo Gene Therapy

According to a recent LinkedIn post from KROMATID, the company is drawing attention to what it describes as...
16h ago
KROMA
VertexOne Showcases Utility Customer Experience Strategy at OUUG 2026

VertexOne Showcases Utility Customer Experience Strategy at OUUG 2026

A LinkedIn post from VertexOne highlights the company’s planned participation in the OUUG 2026 conference, where Vice President...
16h ago
VERTE
AIR Targets Logistics Market With Heavy-Lift Cargo UAS

AIR Targets Logistics Market With Heavy-Lift Cargo UAS

According to a recent LinkedIn post from AIR, the company is positioning a heavy-lift unmanned aircraft system as...
16h ago
AIRXX